Quick Answer
Anixa Biosciences Inc reported Total Assets of $16.08 million for fiscal year 2025.
Anixa Biosciences Inc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $16.08M | -25.5% |
| 2024 | $21.59M | -15.4% |
| 2023 | $25.52M | -16.1% |
| 2022 | $30.41M | -16.1% |
| 2021 | $36.26M | +283.6% |
| 2020 | $9.45M | +50.2% |
| 2019 | $6.29M | -2.4% |
| 2018 | $6.45M | -26.8% |
| 2017 | $8.81M | +56.6% |
| 2016 | $5.63M | -39.7% |
| 2015 | $9.34M | +3.1% |
| 2014 | $9.06M | +66.5% |
| 2013 | $5.44M | -3.9% |
| 2012 | $5.66M | -34.5% |
| 2011 | $8.65M | -13.9% |
| 2010 | $10.05M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $15.23M | -19.4% | -5.3% |
| October 31, 2025 | $16.08M | -25.5% | -8.9% |
| July 31, 2025 | $17.65M | -22.9% | +4.0% |
| April 30, 2025 | $16.98M | -30.3% | -10.2% |
| January 31, 2025 | $18.91M | -25.5% | -12.4% |
| October 31, 2024 | $21.59M | -15.4% | -5.7% |
| July 31, 2024 | $22.91M | -13.8% | -5.9% |
| April 30, 2024 | $24.36M | -11.8% | -4.0% |
- Anixa Biosciences Inc showed a decrease of -25.5% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Anixa Biosciences Inc’s total assets has grown by 60.1% (from $10.05 million to $16.08 million).
- The most recent figure is from Anixa Biosciences Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: